Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and ROS1-Gene Rearrangement: A Case Report
Authors:
- Thamires Oliveira-SilvaTOThamires Oliveira-Silva
- Camila Naegele-BazzanellaCNCamila Naegele-Bazzanella
- Mauro ZukinMZMauro Zukin
- Nicolle CavalcanteNCNicolle Cavalcante
- Antônio Alexandre De-Oliveira-SicilianoADAntônio Alexandre De-Oliveira-Siciliano
- Jaime Araújo-Oliveira-NetoJAJaime Araújo-Oliveira-Neto
- Clarissa BaldottoCBClarissa Baldotto
Open Access
- 9 January 2025
- journal article
- case report
- Published by Georg Thieme Verlag KG in Brazilian Journal of Oncology
- Vol. 21 (CP)
Abstract
Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We report a case of a patient with ROS1-positive NSCLC treated with crizotinib who developed multiple renal and extrarenal cysts and aseptic abscesses associated with a quick resolution of these lesions after the discontinuation of the TKI therapy. We aim to report a rare presentation of a drug-related adverse event with an unusual behavior.Keywords
This publication has 5 references indexed in Scilit:
- Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLCJournal of Cancer Research and Clinical Oncology, 2021
- Crizotinib‐associated renal cyst development may be associated with prolonged progression‐free survival in patients with ALK ‐positive non‐small‐cell lung cancer: Case report and review of the literatureClinical Case Reports, 2021
- Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001Annals of Oncology, 2019
- Renal cyst formation in patients treated with crizotinib for non-small cell lung cancer—Incidence, radiological features and clinical characteristicsLung Cancer, 2017
- Complex renal cysts associated with crizotinib treatmentCancer Medicine, 2015